190 related articles for article (PubMed ID: 19455905)
21. Patterns of amphetamine use in New Zealand: findings from the 2001 National Drug Survey.
Wilkins C; Pledger M; Bhatta K; Casswell S
N Z Med J; 2004 Mar; 117(1190):U796. PubMed ID: 15107899
[TBL] [Abstract][Full Text] [Related]
22. Clinical effects and management of methamphetamine abuse.
Romanelli F; Smith KM
Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with professional support access among a prospective cohort of methamphetamine users.
Quinn B; Stoové M; Dietze P
J Subst Abuse Treat; 2013 Aug; 45(2):235-41. PubMed ID: 23522848
[TBL] [Abstract][Full Text] [Related]
24. Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China.
Liao M; Kang D; Tao X; Li J; Qian Y; Wang G; Jiang B; Bi Z; Jia Y
AIDS Care; 2013; 25(10):1236-44. PubMed ID: 23394142
[TBL] [Abstract][Full Text] [Related]
25. Maintaining class, producing gender: enhancement discourses about amphetamine in entertainment media.
McKenna SA
Int J Drug Policy; 2011 Nov; 22(6):455-62. PubMed ID: 21959088
[TBL] [Abstract][Full Text] [Related]
26. Methamphetamine--what primary care practitioners need to know.
McAvoy BR
J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
[No Abstract] [Full Text] [Related]
27. Epidemiology and public health Consequences of methamphetamine use in California's Central Valley.
Gibson DR; Leamon MH; Flynn N
J Psychoactive Drugs; 2002; 34(3):313-9. PubMed ID: 12422943
[TBL] [Abstract][Full Text] [Related]
28. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.
Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E
Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217
[TBL] [Abstract][Full Text] [Related]
29. A new survey of methamphetamine users in treatment: who they are, why they like "meth," and why they need additional services.
Maxwell JC
Subst Use Misuse; 2014 May; 49(6):639-44. PubMed ID: 24093526
[TBL] [Abstract][Full Text] [Related]
30. Kentucky rural stimulant use: a comparison of methamphetamine and other stimulant users.
Stoops WW; Tindall MS; Havens JR; Oser CB; Webster JM; Mateyoke-Scrivner A; Wright PB; Booth BM; Leukefeld CG
J Psychoactive Drugs; 2007 Nov; Suppl 4():407-17. PubMed ID: 18284106
[TBL] [Abstract][Full Text] [Related]
31. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
McKetin R; Kelly E
Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
[TBL] [Abstract][Full Text] [Related]
32. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
[TBL] [Abstract][Full Text] [Related]
33. Peer-engagement and its role in reducing the risky behavior among crack and methamphetamine smokers of the Downtown Eastside community of Vancouver, Canada.
Jozaghi E; Lampkin H; Andresen MA
Harm Reduct J; 2016 Jun; 13(1):19. PubMed ID: 27278459
[TBL] [Abstract][Full Text] [Related]
34. Crazy for Ya Ba: methamphetamine use among northern Thai youth.
Cohen A
Int J Drug Policy; 2014 Jul; 25(4):776-82. PubMed ID: 25067795
[TBL] [Abstract][Full Text] [Related]
35. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
[TBL] [Abstract][Full Text] [Related]
36. [Methamphetamine Use in Central Germany: A Qualitative Study on Consumer Groups and Motives from the Experts' Perspective].
Hoffmann L; Schumann N; Richter M
Psychother Psychosom Med Psychol; 2018 Aug; 68(8):329-336. PubMed ID: 28895615
[TBL] [Abstract][Full Text] [Related]
37. Stimulant abuse treatment as HIV prevention.
Shoptaw S; Reback CJ; Frosch DL; Rawson RA
J Addict Dis; 1998; 17(4):19-32. PubMed ID: 9848029
[TBL] [Abstract][Full Text] [Related]
38. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.
Callaghan RC; Cunningham JK; Verdichevski M; Sykes J; Jaffer SR; Kish SJ
Drug Alcohol Depend; 2012 Oct; 125(3):290-4. PubMed ID: 22503689
[TBL] [Abstract][Full Text] [Related]
39. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
Chalmers J; Lancaster K; Hughes C
Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
[TBL] [Abstract][Full Text] [Related]
40. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
Firestone M; Goldman B; Fischer B
Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
